Guidance Notes and Best Practice Guides
EHRC: The Equality & Human Rights Commission has published a new guide to help local authorities better understand their human rights obligations when commissioning & procuring home care for older people in England.
Nearly 500,000 older people receive essential care in their own home paid for wholly or partly by their local authority and the guide follows the Commission's in-depth formal Inquiry into the human rights of older people in home care.
ONS: The Office for National Statistics (ONS) has published further analysis & tools to aid the understanding & monitoring of National Well-being. In a report entitled ‘What matters most to personal well-being?’ the question of what is most important to people’s own views about their own well-being is examined.
Press release & links
Press release & links
DfT: A new online resource to help teachers plan road safety lessons for schoolchildren has been launched. The THINK! resource centre brings together a wide range of road safety materials for children & teenagers in one place. It will allow teachers, road safety officers and anyone teaching road safety to plan lessons easily & effectively.
DUK: The use of a new drug for some people with Type 2 diabetes has been recommended in final draft guidance issued by the National Institute for Health and Clinical Excellence (NICE). The drug, dapagliflozin, helps to maintain blood glucose control by the blocking the re-absorption of glucose in the kidneys and promoting excretion of excess glucose in the urine.
The draft NICE guidance recommends the use of dapagliflozin, which is also known as Forxiga, in combination with metformin, which acts to lower blood glucose levels. In some cases, dapagliflozin can also be used in combination with insulin.
The manufacturers of the drug, Bristol-Myers Squibb and AstraZeneca, estimate that it could be suitable for up to 1m UK patients. Dapagliflozin has not been recommended for use in treating Type 1 diabetes.
The manufacturers of the drug, Bristol-Myers Squibb and AstraZeneca, estimate that it could be suitable for up to 1m UK patients. Dapagliflozin has not been recommended for use in treating Type 1 diabetes.
FSA: A new industry guide to good hygiene practice for whitefish processors is available to order from The Stationery Office (TSO). Produced by the Grimsby Fish Merchants Association, on behalf of the industry, the guide aims to help processors to comply with food safety & hygiene law and is recognised by the Food Standards Agency.
HSE: Local authorities are being banned from unnecessary health & safety inspections under a new code which came into effect last week. Tens of thousands of businesses will be removed from H&S inspections which are not justified on a risk basis, including most shops & offices. Checks will continue on poor performers and at sites where there are higher risk activities - See ‘Business and Other Briefings’ section for more information.
.gif)
